Analyst Insights

William Blair Raises InterMune’s Price Target To $74 Following Acquisition By Roche

On Sunday, August 24, Roche (RHHBY) and InterMune (NASDAQ:ITMN) announced that a definitive merger agreement has been reached under which Roche will acquire InterMune …

Roth Capital Maintains Buy On Lannett Following Earnings Preannouncement

In a report published today, Roth Capital analyst Scott Henry maintained a Buy rating on Lannett Company (LCI) with a $45 price target, after the company announced that it expects …

Roth Capital Maintains Buy On Alcobra Following First Patient Enrollment In Fragile X Study

In a research report published today, Roth Capital analyst Debjit Chattopadhyay reiterated a Buy rating on Alcobra Pharma (NASDAQ:ADHD), following first patient enrollment in a phase IIb study on …

Analyst Vs. Analyst: Intuit Inc. – Who Do You Side With?

Intuit Inc. (NASDAQ: INTU) is a Mountain View, California based American software company that develops financial and tax preparation software and associated services for …

Sterne Agee Reiterates Buy On Skechers Shares, $70 PT

In a research report issued today, Sterne Agee analyst Sam Poser reiterated a Buy rating on Skechers USA Ltd. (NYSE:SKX) with a price …

Sterne Agee Assigns Buy On Foot Locker Shares, Raises PT To $65

In a research report issued today, Sterne Agee analyst Sam Poser assigned a Buy rating on Foot Locker Inc (NYSE:FL) with a price target …

Sterne Agee Maintains Buy On Genesco Shares, $90 PT

In a research report issued today, Sterne Agee analyst Sam Poser maintained a Buy rating on Genesco Inc. (NYSE:GCO) with a price target …

Sterne Agee Reiterates Neutral On Hibbet Sports Shares

In a research report issued today, Sterne Agee analyst Sam Poser reiterated a Neutral rating on Hibbet Sports Inc. (NASDAQ:HIBB).

Canaccord Reiterates Buy On Keurig Green Following Licensing Agreement With Kraft Foods

In a report published August 22, analyst Scott Van Winkle of Canaccord reiterated a Buy rating on Keurig Green Mountain (NASDAQ:GMCR) and raised his price target by 10% to $134 (from $122) …

Salesforce: We Remain Long-Term Buyers Based On Growth Opportunities, Says William Blair

Salesforce.com (NYSE: CRM) reported what’s consider to be a very clean quarter—revenue was $31 million above consensus, non-GAAP EPS a penny better, and …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts